Melatonin

With peptides

Melatonin pairs naturally with the Russian-origin sleep and cognitive peptide cluster. DSIP (delta sleep-inducing peptide) operates directly on slow-wave sleep architecture — peptide-level intervention on sleep depth at a different layer than melatonin's circadian signaling. Selank (a tuftsin analog) provides anxiolytic effects via GABA modulation — useful when sleep is blocked by anxious arousal rather than circadian timing. The melatonin + DSIP + Selank stack covers three different sleep mechanism layers: circadian signaling (melatonin), slow-wave architecture (DSIP), and arousal/anxiety modulation (Selank). For longevity-focused users: Epitalon is a pineal-axis peptide that may support endogenous melatonin production — though melatonin supplementation and Epitalon's circadian effects partly overlap. Mechanistically complementary across the sleep peptide cluster; no known negative interactions.

With supplements

1. Apigenin — GABA-A positive allosteric modulator with botanical sleep + longevity arms. Pairs cleanly with melatonin's circadian arm via different receptor system.
2. Glycine — body-temperature regulation for sleep onset (3 g pre-bed). Different sleep mechanism from melatonin; mechanistically complementary. Both target sleep onset via different layers.
3. Magnesium glycinate — GABAergic and neuromuscular relaxation. Standard sleep-stack co-occupant; doesn't interfere with melatonin's circadian signaling.
4. Tart cherry — natural melatonin + tryptophan + anthocyanin botanical matrix. Provides gentle melatonin signal alongside supplemental melatonin; reasonable for users wanting smaller-dose supplemental melatonin with botanical layering.
5. L-theanine — alpha-wave relaxation for pre-sleep mental wind-down. Useful when sleep is blocked by mental chatter; complements melatonin's circadian signaling.
6. GABA — direct GABAergic supplementation. Variable absorption (blood-brain barrier penetration is debated); compatible with melatonin if effective for individual user.

With lifestyle

1. Consistent sleep schedule. Melatonin works best on top of consistent timing. Variable bedtimes undermine the circadian-signaling effect melatonin is designed to support.
2. Evening light reduction. Dim/red light 1–2 hours before bed supports endogenous melatonin production; bright/blue light suppresses it. Light hygiene + supplemental melatonin is the standard circadian protocol.
3. Cool bedroom (~65–68°F / 18–20°C). Supports the body-temperature drop melatonin facilitates. Hot bedrooms blunt the cooling cascade.
4. Pre-flight jet lag protocol. Start adjusting melatonin timing 2–3 days before travel for eastward shifts (most disruptive direction). Take at destination bedtime, not flight bedtime.
5. Intermittent use preferred for chronic protocols. Given the November 2025 AHA long-term safety question, situational/intermittent use rather than nightly multi-year use is the conservative approach pending more evidence.
6. CBT-I for chronic insomnia. Cognitive-behavioral therapy for insomnia is first-line for clinical insomnia disorder; melatonin is an adjunct, not a substitute for behavioral therapy when sleep issues are chronic and severe.

Common (mostly transient)

1. Morning grogginess — particularly with higher doses (5+ mg) and extended-release formulations. Resolves with lower dose or switch to immediate-release.
2. Vivid dreams or nightmares — relatively common, particularly at higher doses. Some users find this disturbing; others find it interesting. Lower dose typically reduces.
3. Headache — occasional, generally mild.
4. Daytime drowsiness — uncommon with proper timing; more likely with extended-release or evening dosing.

Less common (watch-list)

1. Long-term cardiovascular signal (AHA 2025 preliminary). The November 2025 American Heart Association preliminary observational analysis of >130,000 adults raised concerns about elevated heart failure hospitalization and all-cause mortality in long-term (12+ months) melatonin users. Observational data, not peer-reviewed RCT evidence, cannot prove causation. But it adds material uncertainty to the prior "long-term safe" framing. Consider intermittent rather than nightly use for chronic protocols.
2. Hormonal pathway concerns in children — melatonin is a hormone; chronic supplementation during development may affect puberty timing or related axes. Pediatric use should be under specialist supervision for clinical indications only.
3. Label-vs-actual content variance — independent testing has documented significant melatonin content variance from labeled dose in some commercial products. Third-party tested brands preferred.
4. Mood changes — rare reports of depression or irritability worsening; mostly anecdotal.

Drug and supplement interactions

1. Anticoagulants (warfarin, apixaban, rivaroxaban). Mild additive anticoagulant effect possible. Monitor INR for warfarin users.
2. Immunosuppressants (cyclosporine, tacrolimus). Melatonin can affect immune-modulator drug metabolism. Coordinate with prescribing clinician.
3. Diabetes medications. Melatonin may affect glucose metabolism; modest interaction. Monitor glucose if combined with insulin or oral diabetes medications.
4. Hormonal contraceptives. Can increase circulating melatonin levels (estrogen affects melatonin metabolism). May amplify melatonin's effects.
5. Sedatives (benzodiazepines, Z-drugs). Additive sedation. Generally tolerated but watch total sedation load.
6. Fluvoxamine (SSRI) — significantly increases melatonin levels via CYP1A2 inhibition. Lower melatonin dose if on fluvoxamine.
7. Pregnancy and breastfeeding — limited data; defer to clinician. Melatonin crosses the placenta and enters breast milk.

What's the best dose of melatonin to start with?

0.5–3 mg taken 30–60 minutes before bed, lower is better. The 2024 Journal of Pineal Research dose-response meta-analysis mapped the sleep-effect curve and found it plateaus around 4 mg/day — going higher produces no additional benefit and increases next-day grogginess and vivid dreams. Most retail products are dosed at 3, 5, or 10 mg — far above the curve plateau and 10–30× higher than your body's natural peak nighttime production (~0.3 mg equivalent). Start at 0.3–1 mg; escalate to 3 mg only if needed. The 5–10 mg supermarket doses are marketing optimization, not biology.

Is melatonin actually safe for nightly long-term use?

Short-term use (up to a few months) at low doses appears safe with no concerning signal across the trial base. Long-term nightly use — particularly stretching beyond 12 months — has been less studied, and a November 2025 American Heart Association preliminary observational analysis of >130,000 adults raised concerning signals about elevated heart failure hospitalization and all-cause mortality in long-term users vs non-users. This is observational data, not peer-reviewed RCT evidence, and cannot prove causation — but it does mean the long-term safety picture is genuinely incomplete in a way earlier research hadn't surfaced. For nightly use beyond a few months, talk to your doctor and consider whether you actually need it nightly or can use it situationally for circadian disruptions.

Does melatonin cause grogginess in the morning?

At low doses (0.5–3 mg), most users don't experience next-day grogginess. Higher doses (5–10 mg) and extended-release formulations are significantly more likely to cause morning fogginess, vivid dreams, and that 'hung over' feeling. If you wake up groggy, lower your dose first; switch from extended-release to immediate-release second. Slow CYP1A2 metabolizers (about half the population, same enzyme that metabolizes caffeine) may experience longer-lasting effects and benefit from even lower doses (0.1–0.3 mg).

Is melatonin a sedative, or just a circadian signal?

More a circadian signal than a sedative. Melatonin works through MT1 and MT2 receptors to communicate 'it's nighttime' to your brain and body — it doesn't knock you out the way benzodiazepines or Z-drugs do. This is why it's most useful for circadian rhythm disruption (jet lag, shift work, delayed sleep phase disorder) and less useful for forcing sleep when your body isn't ready. Effect sizes in general insomnia trials are modest (~7 minutes faster sleep onset, ~8 minutes additional total sleep time per 2013 meta-analysis) — meaningful but not dramatic. For severe insomnia, melatonin is rarely sufficient as monotherapy.

Can I stack melatonin with DSIP or other sleep peptides?

Yes — and the stack is mechanistically natural for users layering sleep interventions across different mechanisms. DSIP (delta sleep-inducing peptide) operates directly on slow-wave sleep architecture — peptide-level intervention on sleep depth at a different layer than melatonin's circadian signaling. Selank (a tuftsin analog) provides anxiolytic effects via GABA modulation — useful when sleep is blocked by anxious arousal rather than circadian timing. The melatonin + DSIP + Selank stack covers three different sleep mechanism layers: circadian signaling (melatonin), slow-wave architecture (DSIP), and arousal/anxiety modulation (Selank). Add apigenin (GABA-A modulator) for a botanical fourth layer. Mechanistically complementary, no known negative interactions. Particularly useful for travel, shift work, or chronic sleep disruption where single-mechanism interventions underperform.

Can children take melatonin?

Under medical supervision for specific clinical indications — yes. For routine self-administration in healthy children — no. Melatonin is a hormone, and there are open questions about whether chronic supplementation during development affects puberty timing, growth hormone axis, or other hormonal pathways. Most pediatric guidelines reserve melatonin for children with neurodevelopmental sleep disturbances (autism spectrum disorder, ADHD-related sleep issues), and only under pediatrician guidance. The recent explosion in retail melatonin gummies marketed for kids is poorly aligned with the available evidence base. Talk to your pediatrician before starting.

Why are EU and UK melatonin doses different from US?

Regulatory framing differs significantly. In the US, melatonin is sold as a dietary supplement (not FDA-regulated as a drug), available over-the-counter at any dose. In the EU and UK, melatonin is regulated as a prescription medication (under brand names like Circadin), typically at 2 mg extended-release for primary insomnia in adults over 55. The European regulatory bodies took a more conservative position on melatonin's hormone status; the US treats it as a supplement. Practical effect: US users have access to a wider dose range with less quality control; EU/UK users get tighter pharmaceutical-grade dosing but need a prescription.

How long until melatonin works, and how long does the effect last?

Peak plasma concentration in 30–60 minutes after oral dose. The half-life of immediate-release melatonin is 30–50 minutes — short enough that effects are largely gone by morning. Extended-release formulations (Circadin and similar) extend the effect over 6–8 hours but are more likely to cause morning grogginess. For sleep onset (the most common use case): take 30–60 minutes before target bedtime. For circadian phase-shifting protocols (jet lag, shift work): timing varies based on the specific shift direction. Don't take melatonin in the middle of the night — the circadian signaling can backfire.